BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38444377)

  • 1. Extended excess hazard models for spatially dependent survival data.
    Amaral AVR; Rubio FJ; Quaresma M; Rodríguez-Cortés FJ; Moraga P
    Stat Methods Med Res; 2024 Apr; 33(4):681-701. PubMed ID: 38444377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual frailty excess hazard models in cancer epidemiology.
    Rubio FJ; Putter H; Belot A
    Stat Med; 2023 Mar; 42(7):1066-1081. PubMed ID: 36694108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible Bayesian excess hazard models using low-rank thin plate splines.
    Quaresma M; Carpenter J; Rachet B
    Stat Methods Med Res; 2020 Jun; 29(6):1700-1714. PubMed ID: 31502511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.
    Danieli C; Bossard N; Roche L; Belot A; Uhry Z; Charvat H; Remontet L
    Biostatistics; 2017 Jul; 18(3):505-520. PubMed ID: 28334368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of model misspecification in shared frailty survival models.
    Gasparini A; Clements MS; Abrams KR; Crowther MJ
    Stat Med; 2019 Oct; 38(23):4477-4502. PubMed ID: 31328285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On a general structure for hazard-based regression models: An application to population-based cancer research.
    Rubio FJ; Remontet L; Jewell NP; Belot A
    Stat Methods Med Res; 2019 Aug; 28(8):2404-2417. PubMed ID: 30068256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death.
    Belot A; Rondeau V; Remontet L; Giorgi R;
    Stat Med; 2014 Aug; 33(18):3147-66. PubMed ID: 24639014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of baseline hazards in joint modeling of longitudinal and time-to-event cancer survival data.
    Hari A; Jinto EG; Dennis D; Krishna KMNJ; George PS; Roshni S; Mathew A
    Stat Appl Genet Mol Biol; 2024 Jan; 23(1):. PubMed ID: 38736398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted survival benefit with right-censored data.
    Zhang S; LeBlanc ML; Zhao YQ
    Biom J; 2022 Apr; 64(4):696-713. PubMed ID: 34970772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating net survival: the importance of allowing for informative censoring.
    Danieli C; Remontet L; Bossard N; Roche L; Belot A
    Stat Med; 2012 Apr; 31(8):775-86. PubMed ID: 22281942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On models for the estimation of the excess mortality hazard in case of insufficiently stratified life tables.
    Rubio FJ; Rachet B; Giorgi R; Maringe C; Belot A
    Biostatistics; 2021 Jan; 22(1):51-67. PubMed ID: 31135884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non-linear and non-proportional effects of covariates.
    Charvat H; Remontet L; Bossard N; Roche L; Dejardin O; Rachet B; Launoy G; Belot A;
    Stat Med; 2016 Aug; 35(18):3066-84. PubMed ID: 26924122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power and sample size calculations for interval-censored survival analysis.
    Kim HY; Williamson JM; Lin HM
    Stat Med; 2016 Apr; 35(8):1390-400. PubMed ID: 26643411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.
    Eloranta S; Lambert PC; Andersson TM; Czene K; Hall P; Björkholm M; Dickman PW
    BMC Med Res Methodol; 2012 Jun; 12():86. PubMed ID: 22726307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct modelling of age standardized marginal relative survival through incorporation of time-dependent weights.
    Lambert PC; Syriopoulou E; Rutherford MR
    BMC Med Res Methodol; 2021 Apr; 21(1):84. PubMed ID: 33894741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression models for interval censored data using parametric pseudo-observations.
    Johansen MN; Lundbye-Christensen S; Larsen JM; Parner ET
    BMC Med Res Methodol; 2021 Feb; 21(1):36. PubMed ID: 33588771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of covariate effects on net survivals in the relative survival progressive illness-death model.
    Azarang L; Giorgi R;
    Stat Methods Med Res; 2021 Jun; 30(6):1538-1553. PubMed ID: 33966509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new framework for semi-Markovian parametric multi-state models with interval censoring.
    Aastveit ME; Cunen C; Hjort NL
    Stat Methods Med Res; 2023 Jun; 32(6):1100-1123. PubMed ID: 37039362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible modeling of the effects of continuous prognostic factors in relative survival.
    Mahboubi A; Abrahamowicz M; Giorgi R; Binquet C; Bonithon-Kopp C; Quantin C
    Stat Med; 2011 May; 30(12):1351-65. PubMed ID: 21432891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.